secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001193125-25-044151
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kymera grants PSUs to key employees with three clinical milestone vesting targets
--------------------------------------------------------------------------------

- PSUs vest in three installments: 40% for first milestone, 40% for second, 20% for third.
- No PSUs vest before first anniversary of grant date; total payout ranges 0-100% of target.
- Grants approved March 3, 2025 under 2020 Stock Plan for named executive officers and management.
- Target number of PSUs not disclosed; full award terms to be filed in Q1 2025 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/0001193125-25-044151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/d940925d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-044151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer